- Open Access
Quantitative assessment of mitochondrial DNA copies from whole genome sequencing
BMC Genomics volume 13, Article number: S5 (2012)
Mitochondrial dysfunction is associated with various aging diseases. The copy number of mtDNA in human cells may therefore be a potential biomarker for diagnostics of aging. Here we propose a new computational method for the accurate assessment of mtDNA copies from whole genome sequencing data.
Two families of the human whole genome sequencing datasets from the HapMap and the 1000 Genomes projects were used for the accurate counting of mitochondrial DNA copy numbers. The results revealed the parental mitochondrial DNA copy numbers are significantly lower than that of their children in these samples. There are 8%~21% more copies of mtDNA in samples from the children than from their parents. The experiment demonstrated the possible correlations between the quantity of mitochondrial DNA and aging-related diseases.
Since the next-generation sequencing technology strives to deliver affordable and non-biased sequencing results, accurate assessment of mtDNA copy numbers can be achieved effectively from the output of whole genome sequencing. We implemented the method as a software package MitoCounter with the source code and user's guide available to the public at http://sourceforge.net/projects/mitocounter/.
Human mitochondria contain multiple copies of a 16.5 k bp, double-stranded, circular DNA molecule (Figure 1a). Since mitochondria are the organelles that generate chemical energy for cellular functions, many disease symptoms are linked to mitochondrial dysfunction, including poor growth, muscle weakness, hearing problems, visual problems, heart diseases, and liver diseases. There were many recent studies which showed significantly reduced mitochondrial DNA (mtDNA) copy numbers in cell samples of aging-related diseases [1–3]. A recent study also reported that mtDNA copy number is associated with cancer risk . Therefore, quantitative assessment of mtDNA in human cells can elucidate the relationship between mitochondrial diseases and mitochondrial dysfunction.
In the past decade, quantitative real-time PCR assays were developed to estimate relative levels of mtDNA copy numbers in samples [2, 5, 6]. This approach measures the mtDNA copy number by determining the ratio of PCR amplicons to that of a single nuclear gene in experimental samples. The recent development of next-generation sequencing technology (NGS) revolutionized genomic studies and produced accurate whole genome sequencing (WGS) datasets . As shown in Figure 1b, the output from human whole genome sequencing consists of both nuclear DNA (nuDNA) and mitochondrial DNA (mtDNA) molecules, thus it is convenient to assess mtDNA copy number from WGS dataset and can be an alternative to real-time PCR assays.
Here we demonstrate a computational method for counting mtDNA copy number using WGS datasets. The three steps in the process are (1) typing of mtDNA, (2) separation of mtDNA reads, and (3) calculation of mtDNA count. We developed a freely available software package called MitoCounter for this purpose. MitoCounter can be used to calculate the average copy numbers of mtDNA molecules in the sequenced samples. Besides, the separated mtDNA reads provide further analysis of mtDNA heteroplasmy. The mtDNA heteroplasmy represents the mixture of individual mtDNA mutations. Heteroplasmy levels can alter the clinical penetrance of primary mtDNA diseases [8, 9].
A computational assay for counting mtDNA copies from a WGS dataset
Since the library construction bias is minimized with the next-generation sequencing platform , both mitochondrial DNA (mtDNA) and nuclear DNA (nuDNA) are sequenced together with equal opportunities. The output dataset comprises a mixture of mtDNA reads and nuDNA reads. Let the total number of nucleotide bases in the nuclear genome be 2N (for diploid chromosomes) and the number of bases in a mitochondrial DNA is M. Then the summation of nucleotide bases in the entire human genome is 2N+kM, where k is the number of mtDNA copies. The numbers of reads from nuDNA and the number of reads from mtDNA should reflect the ratio of 2N:kM.
where mtBases is the total bases of sequenced reads from mtDNA and allBases is total bases of all sequenced reads from the output of a WGS procedure.
From an entire dataset of human whole genome sequencing, we separate the mtDNA reads from the others. Then the number of mtDNA copies can be approximated as
The equation for counting mtDNA copies is not suitable for plants (e.g. Arabidopsis) since their mtDNA sequences may contain segments of nuclear DNA. Besides, there are usually other DNA molecules in their cells, such as chloroplast genome and plasmid genome.
In order to precisely separate mtDNA reads from a WGS dataset, it is necessary to determine the genotype of the mitochondrial genome first. We designed a program WgsMitoAssembler to identify the homoplasmic sequences, which present the inherent mutations in most of mtDNA molecules. The program WgsMitoAssembler is a guided assembler, and it requires a reference mitochondrial sequence which is used to choose a beginning read and an ending read from the entire WGS dataset. We use the reference mtDNA sequence (GenBank: NC_001807.4) for the purpose. We then search for best candidate reads which can extend the beginning read from the 3' end to the 5' end until the ending read is met.
After the typing of the target mitochondrial genome, the homoplasmy sequence is used in the second program WgsMitoCounter. The program performs the job of separating mitochondrial reads from the entire WGS dataset. Considering that some of sequenced reads may contain erroneous bases, we design an error-tolerant mapping algorithm shown in Figure 2. We search for sub-sequences of paired reads which are indexed as mtDNA fragments and the accuracy of mapping is determined by the pairing distances. WgsMitoCounter will output a CSV file which records the number of mitochondrial reads in each run of the entire dataset. The template of final calculation for mtDNA copy number is provided in Additional file 1.
Results and discussion
Parental mtDNA samples have less copy numbers
We apply the analysis to public WGS datasets from the HapMap  and 1000 Genomes  projects. We chose six high-coverage WGS datasets for two pedigree trios: YOR009 and CEPH146 and two low-coverage WGS datasets for individual elders (Sample ID: NA11831 and NA06985), listed in Table 1. YOR009 is an African family. CEPH1463 is a family from Utah with Northern and Western European ancestry. The two individuals are also from the CEPH population and were recorded as the grandparents in the 1000 Genomes project. These DNA samples were isolated from B-lymphocyte cells derived from blood. Table 2 lists the results of counting mitochondrial DNA on the selected datasets. The mtDNA counts for the YOR009 family are between 645~752 and for CEPH1463 family are between 734~950. Besides, the mtDNA counts for the two individual elders are 662 and 755.
For the counting results of these WGS samples (Additional file 2 and 3), ANOVA analysis revealed significant differences among the mtDNA counts within each family group: for YOR009, F(2,69) = 916.01, p = 2.06E-50 and for CEPH1463, F(2,169) = 58.75, p = 7.26632E-19. It showed that the offspring had 8%~23% more mtDNA than their parents in these samples. Although we did not investigate the possible artefacts caused by sequencing procedures, the results consistently demonstrated that there are more mtDNA sequences within younger persons' lymphocyte cells.
Many studies suggested that mitochondrial functions become defective as we age. Recent findings suggests that structural changes in mitochondria, including increased mitochondrial fragmentation and decreased mitochondrial fusion, are critical factors associated with mitochondrial dysfunction and cell death in aging and neurodegenerative diseases [13, 14]. Therefore, the proposed quantitative analysis of mtDNA can help to further elucidate the dynamics of mitochondrial diseases. It is expected that cost for sequencing personal whole genome will be less than $1000 in the near future. For the purpose of counting mitochondrial DNA, it only requires a low coverage of the whole genome and the cost may be further reduced to $50. The cost-effectiveness of the procedure makes the proposed method of counting mitochondrial DNA as a useful diagnostic tool to study aging and aging-related diseases for individuals.
Availability and requirements
In the MitoCounter software package, both the programs WgsMitoAssembler and WgsMitoCounter were implemented in C# with the .NET Framework which can be run on 64-bit Windows. The program WgsMitoCounter requires paired-end WGS datasets from Illumina sequencing platform. The MitoCounter software with a user manual is available at the Web site: http://sourceforge.net/projects/mitocounter/
Maassen JA, LM TH, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM, Lemkes HH: Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 2004, 53 (Suppl 1): S103-109.
Hartmann N, Reichwald K, Wittig I, Drose S, Schmeisser S, Luck C, Hahn C, Graf M, Gausmann U, Terzibasi E, et al: Mitochondrial DNA copy number and function decrease with age in the short-lived fish Nothobranchius furzeri. Aging Cell. 2011, 10 (5): 824-831. 10.1111/j.1474-9726.2011.00723.x.
Cree LM, Patel SK, Pyle A, Lynn S, Turnbull DM, Chinnery PF, Walker M: Age-related decline in mitochondrial DNA copy number in isolated human pancreatic islets. Diabetologia. 2008, 51 (8): 1440-1443. 10.1007/s00125-008-1054-4.
Thyagarajan B, Wang R, Barcelo H, Koh WP, Yuan JM: Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2012
Koekemoer TC, Downing TG, Oelofsen W: An alternative PCR assay for quantifying mitochondrial DNA in crude preparations. Nucleic Acids Research. 1998, 26 (11): 2829-2830. 10.1093/nar/26.11.2829.
Barazzoni R, Short KR, Nair KS: Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem. 2000, 275 (5): 3343-3347. 10.1074/jbc.275.5.3343.
Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, et al: Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008, 456 (7218): 53-59. 10.1038/nature07517.
Sondheimer N, Glatz CE, Tirone JE, Deardorff MA, Krieger AM, Hakonarson H: Neutral mitochondrial heteroplasmy and the influence of aging. Hum Mol Genet. 2011, 20 (8): 1653-1659. 10.1093/hmg/ddr043.
Avital G, Buchshtav M, Zhidkov I, Tuval Feder J, Dadon S, Rubin E, Glass D, Spector TD, Mishmar D: Mitochondrial DNA heteroplasmy in diabetes and normal adults: role of acquired and inherited mutational patterns in twins. Hum Mol Genet. 2012
Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, Jaffe DB, Nusbaum C, Gnirke A: Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011, 12 (2): R18-10.1186/gb-2011-12-2-r18.
Consortium TIHGS: A haplotype map of the human genome. Nature. 2005, 437 (7063): 1299-1320. 10.1038/nature04226.
Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Gibbs RA, Hurles ME, McVean GA: A map of human genome variation from population-scale sequencing. Nature. 2010, 467 (7319): 1061-1073. 10.1038/nature09534.
Beal MF: Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005, 58 (4): 495-505. 10.1002/ana.20624.
Reddy PH, Reddy TP: Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res. 2011, 8 (4): 393-409. 10.2174/156720511795745401.
We thank the members in the Bioinformatics Lab, NTU, for valuable discussions and useful insights. We thank C. S. Chiou, C. H. Chan and C. F. Chang for comments and discussion. We thank Flora Kao for editing and proofreading.
This article has been published as part of BMC Genomics Volume 13 Supplement 7, 2012: Eleventh International Conference on Bioinformatics (InCoB2012): Computational Biology. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcgenomics/supplements/13/S7.
The authors declare that they have no competing interests.
HTC devised the method and wrote the software. HTC, WLH, TTT, CMC, YWL, CCF, HHC, HL, TJY, JCC, DMH and CCC discussed the project and jointly wrote the manuscript. CYK conceived the project.
Electronic supplementary material
Additional File 1: Supplementary Software. The MitoCounter software package consists of two execution programs, an Excel template and a User manual. (XLS 26 KB)
Additional File 2: Supplementary Table 1. An Excel file lists the ratio of mitochondrial reads in each WGS run for the family trio YOR009 samples. (XLS 31 KB)
Additional File 3: Supplementary Table 2. An Excel file lists the ratio of mitochondrial reads in each WGS run for the family trio CEPH1463 samples. (ZIP 2 MB)
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Chu, HT., Hsiao, W.W., Tsao, T.T. et al. Quantitative assessment of mitochondrial DNA copies from whole genome sequencing. BMC Genomics 13 (Suppl 7), S5 (2012). https://doi.org/10.1186/1471-2164-13-S7-S5
- Whole Genome Sequencing
- Mitochondrial Disease
- Heteroplasmy Level
- Individual Elder
- Genome Sequencing Dataset